OMC
FBIO icon

Oasis Management Company’s Fortress Biotech FBIO Stock Holding History

Oasis Management Company’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-65,681
Closed -$645K – 88
2022
Q4 		$645K Hold
65,681
– – 0.13% 57
2022
Q3 		$847K Hold
65,681
– – 0.14% 64
2022
Q2 		$827K Buy
+65,681
New +$973K 0.15% 60

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $72.2B AUM 27.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oasis Management Company's FBIO Position: Q1 2023 in Review

Oasis Management Company sold out of Fortress Biotech (FBIO) in Q1 2023, closing a stake of 65,681 shares — an estimated $645K sold.

Oasis Management Company first reported a position in FBIO in Q2 2022 and held it in 3 quarters. The position peaked at $847K in Q3 2022. 54 funds tracked by Wall St. Rank hold FBIO as of Q1 2023.

  • Oasis Management Company reported no remaining Fortress Biotech position as of Q1 2023 after selling out during the quarter.
  • Oasis Management Company sold 65,681 Fortress Biotech shares in Q1 2023, an estimated $645K.
  • Oasis Management Company first reported a position in Fortress Biotech in Q2 2022 and held it in 3 quarters.
  • Oasis Management Company's Fortress Biotech position peaked at $847K in Q3 2022.
  • 54 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2023.

Based on Oasis Management Company's 13F filing for Q1 2023, filed 15 May 2023.